Table 4.
Recommendations | % of Physicians (N = 611) |
---|---|
Surveillance recommendations for 35-year-old woman with BRCA1 mutation who desires no prophylactic surgery. Recommend … * | |
Monthly breast self-examination | 95.6 |
Clinical breast examination every 6-12 months | 74.3 |
Mammogram every 6-12 months | 95.3 |
Pelvic examination every 6-12 months | 95.9 |
Pelvic ultrasound every 6-12 months | 84.6 |
CA-125 testing every 6-12 months | 74.0 |
Recommend surveillance breast MRI … | |
No | 34.7 |
Every 6 months | 5.7 |
Yearly | 51.7 |
Missing | 7.9 |
38-year-old woman with BRCA1 mutation who has completed childbearing | |
Recommend bilateral prophylactic mastectomy | 61.4 |
Recommend bilateral salpingo-oophorectomy | 84.9 |
38-year-old woman with BRCA1 mutation who has completed childbearing and underwent bilateral prophylactic oophorectomy with hysterectomy | |
Recommend estrogen | 6.6 |
Recommend tamoxifen | 71.2 |
Recommend raloxifene | 33.7 |
Abbreviation: MRI, magnetic resonance imaging.
Time intervals for testing were categorized based on recommendations in published articles and American Society of Clinical Oncology recommendations.